Milanowski, Janusz

• Vol 6, No 2 (2010) - REVIEW ARTICLES
  Molecular factors in individualisation of chemiotherapy in non-small cell lung cancer - is it far future or close present?
  Abstract  PDF (Polish)
• Vol 13, No 1 (2017) - CASE REPORT
  Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma
  Abstract  PDF  HTML
• Vol 14, No 4 (2018) - REVIEW ARTICLES
  The impact of intestinal microflora on the effectiveness of immunotherapy with antibodies against immune checkpoints — case report and literature review
  Abstract  PDF
• Vol 15, No 5 (2019) - CASE REPORT
  Differential diagnosis of autoimmune pituitary failure and pituitary macroadenoma during nivolumab therapy in an NSCLC patient — a case report
  Abstract  PDF
• Vol 16, No 5 (2020) - ORIGINAL ARTICLES
  Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique
  Abstract  PDF
• Vol 16, No 6 (2020) - CASE REPORT
  The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression — focus on intestinal microbiome
  Abstract  PDF
• Vol 17, No 3 (2021) - REVIEW ARTICLES
  Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction
  Abstract  PDF
• Vol 19, No 1 (2023) - CASE REPORTS
  Immunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation
  Abstract  PDF  HTML
• Vol 18, No 3 (2022) - ORIGINAL ARTICLES
  Different MET gene alterations in lung adenocarcinoma patients
  Abstract  PDF  HTML
• Vol 19, No 1 (2023) - ORIGINAL ARTICLES
  Delays in the diagnosis of lung cancer patients in Poland
  Abstract  PDF  HTML
• Vol 19, No 6 (2023) - CASE REPORTS
  Optimizing treatment strategies for a MET exon 14 skipping mutation in non-small-cell lung cancer: a case report of sequential immunotherapy and targeted therapy and literature review
  Abstract  PDF  HTML